Intercept Pharmaceuticals Overview

Intercept Pharmaceuticals Other Income Expense Net

Other Income/Expense Net for ICPT.

Quarterly Other Income/Expense

-$2.60M

As of Sep 30, 2023

Annual Other Income/Expense (TTM)

$1.26M

Trailing 12 months ending Sep 30, 2023

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin